Mrs Loreto Alvarez-Cedron Spain

Faes Farma, a Spanish pharma company founded in 1933, with strong presence in Spain and Portugal and a growing international presence in many countries, including LatAm. Faes includes a total of 1200 employees.

Faes is devoted to R&D, development, manufacturing, promoting and marketing of Rx and OTC products, and Animal health nutrition business.

2017 Net sales 275 mill €, mainly coming from Spain and Portugal pharma & OTC activity, international business and Animal Health units.

Faes is looking for in-licensing opportunities in phase III or commercialization stage, both RX and OTC products. Areas of interest: Bone & Metabolism, GI, Derma, Paediatrics, Allergy, Gynea. 

Website:
www.faes.es
Faes Farma, S. A.
Business Development and Alliance Senior Manager 

Mr Xavier Arnaud Spain

Faes Farma, a Spanish pharma company founded in 1933, with strong presence in Spain and Portugal and a growing international presence in many countries, including LatAm. Faes includes a total of 1200 employees.

Faes is devoted to R&D, development, manufacturing, promoting and marketing of Rx and OTC products, and Animal health nutrition business.

2017 Net sales 275 mill €, mainly coming from Spain and Portugal pharma & OTC activity, international business and Animal Health units.

Faes is looking for in-licensing opportunities in phase III or commercialization stage, both RX and OTC products. Areas of interest: Bone & Metabolism, GI, Derma, Paediatrics, Allergy, Gynea. 

Website:
www.faes.es
Mr Xavier Arnaud
Faes Farma, S. A.
Corporate Director of Business Development 

Mr DANIEL CASADEVALL LOPEZ Spain

Business Development: Partners Pharmaceutical area: Licenses and collaboration agreements

Three factors have led to large experience in licenses and collaborations:

  • The consolidated presence of the Juste Group in the Spanish, Central American, and South American markets.
  • Our in-house developed products.
  • The growing prestige of the company since its beginning.

The Juste Group has a permanent interest in collaborating with development projects and establish license agreements and/or co-promotion for Spain, Portugal, countries from Central and South America, Middle East, and North Africa in the following fields of specialization:

  • Radiology/Contrast medium
JUSTESA IMAGEN, S.A.U.
SALES MANAGER 

Dr CESAR DE OZA Spain

ALMIRALL S.A.
Head of Commercial Business Development - Corporate Development 

Dr Alejandro Delgado Alonso Spain

With 80 years of experience, Italfarmaco develops activities in the entire value chain of pharmaceutical and chemical industry, from manufacturing to commercialization and development.

Group Headquarters are located Milan, with direct presence in 26 countries across Europe, America, Asia and MENA

 

We are interested in licensing-in, product acquisition, M&A and licensing out

Italfarmaco
LinkedIn logo VP Business Development & Exports 

Mr Ashutosh Dharmadhikari Spain

Hetero Europe, SL
Head Business Development Manager 

Mr Francisco Juste Bellosillo Spain

Business Development: Partners Pharmaceutical area: Licenses and collaboration agreements

Three factors have led to large experience in licenses and collaborations:

  • The consolidated presence of the Juste Group in the Spanish, Central American, and South American markets.
  • Our in-house developed products.
  • The growing prestige of the company since its beginning.

The Juste Group has a permanent interest in collaborating with development projects and establish license agreements and/or co-promotion for Spain, Portugal, countries from Central and South America, Middle East, and North Africa in the following fields of specialization:

  • Radiology/Contrast medium
JUSTESA IMAGEN, S.A.U.
Vice President 

Dr Jose Millan Spain

Mundipharma is a global, independent network empowered locally.

We are an asset led, privately owned business, with international presence and in-depth knowledge of the local market.

Our network of independent affiliated companies enables us to leverage our integrated capabilities from discovery to product commercialization.

Built on a tradition of entrepreneurship, our flexibility and way of doing things have allowed us to forge a solid and trustful relationship with our partners, ensuring the sustained success of our business.

Focused on delivering commercial excellence, we actively evaluate opportunities to complement our existing product portfolio, to substantially improve patient’s quality of life.

Dr Jose Millan
Mundipharma
LinkedIn logo Southern European Strategy and Business Development Head 

Mr Marti Monras Spain

LABORATORIOS RUBIO, S.A.
Business Development Manager 

Mr Enrique REMEZAL Spain

 Zaltanpharma is an Innovative pharmaceutical company

We are focus on specialist & hospital products

We offer:

 - Experience and proven sales results

- Support of icon Group, leading service company in the healthcare industry

- Presence in Europe and America

We are interested in:

 Prescription drugs to be promoted in our expertise areas:

- Cardiology

- Rheumatology

- Traumatology

- Psychiatry

- Neurology

- Pain/Musculoskeletal

- Gyneacology

- Urology

We are interested in MA to be launched, mature products and products to be acquired.

We are NOT interested in:

 Generics without any innovation in formulation or dosis

Food supplements

Nutraceuticals

Natural/homeopatic products

Branded products earlier than Phase III

Mr Enrique REMEZAL
ZALTANPHARMA LABORATORIOS S.L
LinkedIn logo CEO